VolitionRx Limited to Attend Conferences in December
Nov 10, 20171:00 PM
Singapore Volition signs Memorandum of Understanding with the National Taiwan University to Conduct Two Large Clinical Studies
Nov 09, 201710:00 PM
VolitionRx Limited Announces Third Quarter 2017 Financial Results and Business Update
Nov 02, 20171:00 PM
VolitionRx Limited Schedules Third Quarter 2017 Earnings Conference Call and Business Update
Sep 22, 20172:00 PM
VolitionRx Announces the Initial Sale of its New Nu.Q(TM) Research Kits
Sep 21, 201710:00 PM
VolitionRx Limited Awarded $1.5 Million in Non-Dilutive Funding
Sep 19, 201710:00 PM
VolitionRx Announces its European Colorectal Cancer Strategy
Sep 15, 20171:00 PM
VolitionRx to Attend Two Major Conferences in Asia
Sep 14, 20172:00 PM
Volition Granted Four Additional Patents
Sep 06, 201710:00 PM
VolitionRx Limited to Attend Multiple Conferences in September
Aug 22, 201710:00 PM
Volition Signs Agreement with the Institute of Laboratory Medicine of the Technical University of Munich, Germany, to assist in securing large trials in a range of cancers
Aug 09, 201710:00 PM
VolitionRx Limited Announces Second Quarter 2017 Financial Results and Business Update
Aug 03, 201710:00 PM
VolitionRx Limited Schedules Second Quarter 2017 Earnings Conference Call and Business Update
Jul 19, 201710:00 PM
VolitionRx Limited to host a conference call regarding a 13,500 Subject Colorectal Cancer Screening Trial with the Early Detection Research Network of the U.S. National Cancer Institute
Jul 18, 201712:00 PM
Volition America, Inc. Announces a Colorectal Cancer Screening Trial containing approximately 13,500 Subjects in Collaboration with the Early Detection Research Network of the U.S. National Cancer Institute
Jun 30, 20173:00 PM
Volition to Present at the EuropaColon Advocacy Masterclass and Exhibit at the European Society for Medical Oncology Gastrointestinal Cancer Congress
Jun 27, 20171:00 PM
VolitionRx Limited Corrects an Earlier Announcement
May 26, 201712:00 PM
VolitionRx Limited to Present at Multiple Investor Conferences in June
May 18, 20173:00 PM
A new publication reports that 91% of colorectal cancers were detected at 90% specificity in a completed prospective trial using Volition's Nu.Q(TM) assays
May 11, 201712:00 PM
VolitionRx Limited Announces First Quarter 2017 Financial Results and Business Update
May 08, 20172:00 PM
VolitionRx Limited Schedules First Quarter 2017 Earnings Conference Call and Business Update
Apr 27, 20171:00 PM
Volition makes progress with its Colorectal Cancer Screening Triage Test in both Asia and Europe
Apr 21, 20172:00 PM
Volition opens a new Research and Development facility in Belgium with a state of the art, purpose-built laboratory
Apr 11, 20171:00 PM
VolitionRx Appoints David Vanston as Chief Financial Officer
Mar 28, 201710:00 PM
Volition America, Inc. Retains Strategic Expert in Securing Non-Dilutive Funding Opportunities in the United States
Mar 20, 20176:30 AM
VolitionRx Limited Announces the Formation of Volition America, Inc.
Mar 14, 20171:56 PM
VolitionRx Limited Celebrates CE Mark Announcement By Ringing Closing Bell at the New York Stock Exchange
Mar 13, 20176:30 AM
VolitionRx Limited to Ring the New York Stock Exchange Closing Bell on Monday, March 13th at 4 pm Eastern Daylight Time
Mar 10, 20176:30 AM
VolitionRx Limited Announces Full Fiscal Year 2016 Financial Results and Business Update
Mar 08, 20176:30 AM
VolitionRx Limited to Present at the 29th Annual ROTH Conference
Mar 06, 20175:00 PM
VolitionRx Limited Schedules Fourth Quarter and Full Year 2016 Earnings Conference Call and Business Update
Mar 02, 20176:30 AM
A Logistics and Pathway Design Study for Volition's CE Marked NuQ(TM) Triage Test has been Commenced in the Capital Region of Denmark
Feb 24, 20176:30 AM
VolitionRx Limited's Triage Test Results Validated in Prospective Trial
Feb 23, 20179:00 AM
VolitionRx Limited to Attend the BTIG 2017 Medical Technology, Life Sciences, and Diagnostics Conference
Feb 09, 20179:26 AM
VolitionRx Limited to Present at Source Capital Group's 2nd Annual Disruptive Growth & Healthcare Conference on February 15, 2017
Jan 05, 20176:30 AM
VolitionRx Limited Strengthens Team with Key Appointment to Drive Sales and Trials in Asia
Jan 03, 20179:00 AM
VolitionRx Limited's Novel Cancer Diagnostic Test Achieves CE Marking as it Prepares for Launch Across Europe